McKesson Europe AG (CAKFY) Stock

About McKesson Europe AG

McKesson Europe AG is a global provider of logistics and a variety of services to the pharmaceutical and healthcare industries. Its operations are structured into two main segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution arm focuses on the wholesale supply of medicines and other health-related products. It reaches approximately 40,000 pharmacies and hospitals via 90 wholesale branches and manages 70 distribution centers across Europe. Meanwhile, the Retail Pharmacy division oversees roughly 2,000 company-owned pharmacies and collaborates with around 8,000 partners through its brand program. Under the Lloyds Pharmacy brand, this segment also delivers outpatient medication services, e-commerce solutions, and home care, principally in Belgium, Ireland, Italy, and the United Kingdom. Its offerings extend to traditional prescription drugs, over-the-counter (OTC) items, and various medical services. Furthermore, it supports pharmacists by organizing and managing pharmacy cooperation initiatives in Great Britain, France, Portugal, and Belgium. Established in 1835, the company's roots trace back to its former identity, Celesio AG, before rebranding as McKesson Europe AG in September 2017. Headquartered in Stuttgart, Germany, it operates as a subsidiary of McKesson Corporation.

McKesson Europe AG is headquartered in DE.

McKesson Europe AG (CAKFY) stock trades at $4.10 with a market capitalization of $5.37B. The stock is valued at a price-to-earnings (P/E) ratio of -73.53, price-to-book of 1.46, price-to-sales of 0.51. Over the past 52 weeks the stock has ranged between $4.02 and $4.81, and currently trades 14.8% below its 52-week high.

On profitability, McKesson Europe AG generates a return on equity (ROE) of -2.26%, return on capital employed of 2.09%, an operating margin of 0.64%, a net profit margin of -0.53%.

Official website: www.mckesson.eu/mck-en